Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Propensity-Matched Analysis of Real-World Data
The Journal of Arthroplasty · 2026
DOI: 10.1016/j.arth.2026.01.027 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2026. Verfasst von Arsen M Omurzakov und 5 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College, New York, New York. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Postoperative Complications, Testosterone, Hormone Replacement Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: While testosterone replacement therapy (TRT) is known to affect cardiovascular physiology, its impact on outcomes following total hip arthroplasty (THA) remains unclear. This study aimed to assess whether preoperative TRT use is associated with increased complications following THA. METHODS: A retrospective cohort study using a large national database was performed. Adult patients undergoing primary THA before February 2020 with 5-year follow-up were stratified based on preoperative TRT use within one year of surgery. Patients who had a history of septic arthritis, osteonecrosis, or pathologic fractures were excluded. Propensity score matching (1:1) was used to balance cohorts. Outcomes included medical complications at 90 days and one year and prosthetic complications up to five years postoperatively. Following matching, 3,953 patients were included in each cohort. RESULTS: At 90 days, TRT use was associated with higher rates of deep vein thrombosis (2.8 versus 2.0%; P = 0.023), pneumonia (3.2 versus 1.7%; P < 0.001), and sepsis (4.2 versus 0.9%; P < 0.001). At one year, TRT users had increased rates of deep vein thrombosis (4.3 versus 3.0%; P = 0.002), cardiac events (2.9 versus 1.7%; P < 0.001), pneumonia (6.1 versus 3.4%; P < 0.001), acute kidney injury (7.6 versus 5.6%; P < 0.001), and sepsis (3.8 versus 1.9%; P < 0.001). At five years, TRT users had higher rates of periprosthetic joint infection (3.1 versus 1.6%; P < 0.001), periprosthetic fracture (2.4 versus 1.4%; P = 0.003), loosening (1.7 versus 1.0%; P = 0.007), prosthetic dislocation (2.5 versus 1.2%; P < 0.001), and revision surgery (4.1 versus 2.3%; P < 0.001). CONCLUSIONS: Preoperative TRT use was associated with increased risk of medical and prosthetic-related complications following THA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Weill Cornell Medical College, New York, New York.
- Case Western Reserve University School of Medicine, Cleveland, Ohio.
- Department of Orthopedic Surgery, Hospital for Special Surgery, New York, New York.
Zitieren
APA
Omurzakov, A. M., Omurzakov, A., Bhatti, P., Debbi, E. M., Gausden, E. B., & Chalmers, B. P. (2026). Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Propensity-Matched Analysis of Real-World Data. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2026.01.027
Vancouver
Omurzakov AM, Omurzakov A, Bhatti P, Debbi EM, Gausden EB, Chalmers BP. Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Propensity-Matched Analysis of Real-World Data. The Journal of Arthroplasty. 2026. doi:10.1016/j.arth.2026.01.027
BibTeX
@article{Omurzakov2026,
author = {Omurzakov, Arsen M and Omurzakov, Argen and Bhatti, Pravjit and Debbi, Eytan M and Gausden, Elizabeth B and Chalmers, Brian P},
title = {Preoperative Testosterone Replacement Therapy Is Associated With Increased Complication Risk After Total Hip Arthroplasty: A Propensity-Matched Analysis of Real-World Data},
journal = {The Journal of Arthroplasty},
year = {2026},
doi = {10.1016/j.arth.2026.01.027}
}
EUVIMED